Free Trial

Gerresheimer (ETR:GXI) Trading Down 1.3% - What's Next?

Gerresheimer logo with Medical background

Gerresheimer AG (ETR:GXI - Get Free Report)'s stock price was down 1.3% during trading on Friday . The company traded as low as €63.20 ($72.64) and last traded at €63.20 ($72.64). Approximately 114,007 shares were traded during trading, a decline of 19% from the average daily volume of 140,925 shares. The stock had previously closed at €64.05 ($73.62).

Gerresheimer Trading Up 0.2%

The stock's fifty day moving average price is €59.61 and its 200 day moving average price is €68.90. The company has a quick ratio of 0.40, a current ratio of 0.80 and a debt-to-equity ratio of 87.94. The stock has a market cap of $2.17 billion, a PE ratio of 18.98, a PEG ratio of 0.82 and a beta of 0.94.

About Gerresheimer

(Get Free Report)

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.

See Also

Should You Invest $1,000 in Gerresheimer Right Now?

Before you consider Gerresheimer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gerresheimer wasn't on the list.

While Gerresheimer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines